Robert Sutherland Smith

AstraZeneca: Back in the Takeover Crosshairs?

AstraZeneca: Back in the Takeover Crosshairs?

4 mins. to read

Bad news at Phase III: a potential buy on share price weakness. Following Post Brexit sterling weakness, foreign takeover prospects prevent it from being the obvious sell it might otherwise be. The sterling value of the abortive Pfizer bid at 5,500p is now, after devaluation of the pound, worth a notional 6,000p.          Astra Zeneca looks,…

Centrica: Out of the Woods?

Centrica: Out of the Woods?

4 mins. to read

Centrica’s cash position has improved markedly suggesting that the current prospective dividend yield at an estimated 5.3% looks sustainable. There is also the support of a significant net asset backing for the shares. For those seeking income, Centrica looks like a dividend stock to accumulate at these levels.   To most of us, Centrica presents a…

VAT Cut to Buoy Next?

VAT Cut to Buoy Next?

4 mins. to read

Next (LON:NXT) at 5,250p, after the second-quarter trading statement, looks lowly rated, both absolutely and historically, and provides an excellent vehicle to ride the sentiment effect of a Gordon Brown-like stimulation of the economy – successfully achieved in 2010 when the UK economy began growing again despite the alarming impact of a world banking crisis.  There are…

GKN Is Geared for Growth

GKN Is Geared for Growth

4 mins. to read

GKN at 290p have pulled back a little on the half-year results. If they were to move down towards 260p again they would be attractive on an estimated dividend yield of 3.6 per cent. In the three years to 31st December 2015 (the financial year end) GKN (LON:GKN), the aviation and automotive engineering company, had two structural…

HSBC: A Brexit Beneficiary?

HSBC: A Brexit Beneficiary?

4 mins. to read

HSBC (HSBA) at 492p: investors can now buy HSBC shares at half the price they were seven or eight years ago on a valuation which is a 33 per cent discount to net assets and on a dividend yield of over 7 per cent. That seems to discount a lot and leave room for long-term appreciation. A little…

Lloyds Banking: A Brexit Bargain?

Lloyds Banking: A Brexit Bargain?

4 mins. to read

Bank shares await the verdict of post-Brexit economic history. The share price chart for Lloyds at 54p gives little guidance. However, well capitalised and on above-average earnings and dividend yields (an estimated 13.6% and 7.4% consensus last seen) the shares look a hold and a speculative buy for those who take a more cheerful view of…

British Land Has Income Attractions

British Land Has Income Attractions

4 mins. to read

Property company shares, like British Land (BLND), are about location, quality of covenant (i.e. are the leaseholders good for the rent?) and rental yield. But like all equities they are also about quality of management. The management of British Land has played the UK’s recent and remarkable UK property boom brilliantly. Beginning speculatively and ending conservatively, with…

Burberry’s Brexit Bounce

Burberry’s Brexit Bounce

4 mins. to read

On recent consensus estimated prospective PER of 16 and an estimated forecast annual dividend yield of 3.4% the shares have lost their premium. The share price is well supported by 350p of net assets commanding an enterprise value of around 520p a share.    I have not been much attracted to Burberry shares for a year…

M&S – on the cusp of an exciting speculation

M&S – on the cusp of an exciting speculation

4 mins. to read

Marks & Spencer at 315p post Brexit and post Q1 Trading statement (Pre Brexit.)  How Brexit might radically change things? Earnings would seem to have to fall a long way to make these shares seem dear. In the midst of the mountain slide of domestic UK share market capitalizations came the results from Marks &…